A Combined GWAS and miRNA for the Identification of Bevacizumab Response Predictors in Metastatic Breast Cancer

NCT01598285 · clinicaltrials.gov ↗

TERMINATED

Status

26

Enrollment

OTHER

Sponsor class

Stopped Due to the low rate of recruitment.

Conditions

Breast Cancer Invasive Nos

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]
[object Object]